Dorsal Displacement Clinical Trial
Official title:
Nonoperative Treatment of Dorsally Dislocated Distal Radius Fractures in Adults With an Individualized 3D Printed Brace; a Tolerability Study in Healthy Volunteers and Patients (DRFB)
Verified date | February 2019 |
Source | VieCuri Medical Centre |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Study design: Two consecutive prospective case series. Study population: Part 1 will enroll
10 healthy volunteers (50 years or older). Part 2 will enroll 10 elderly patients (50 years
or older) with a dorsally displaced distal radius fracture (AO type 23-A-C) that is
acceptably reduced. In both parts, participants should have no restrictions in activities of
daily living pre-fracture and no evident anatomical difference between both wrists.
Intervention:
Part 1: Participants will wear the brace continuously for one week. Part 2: Participants will
wear the brace as treatment of the fracture for five weeks (instead of a plaster cast).
Main study parameters/endpoints: In parts 1 and 2, the primary outcome measure will be a
Visual Analog Scale (VAS) score for wearing comfort. Secondary outcome measures are the
occurrence of fracture redislocation (part 2 only), pain (VAS), inconvenience during
NL61002.078.17 / DRFB-Tolerability Distal Radius Fracture Brace Tolerability Version number:
1.1, d.d. April 24, 2017 8 of 34 activities of daily living (Katz Index), and adverse
reactions like pain, skin pressure, skin irritation/redness, sensibility issues, or
device-related problems.
Status | Completed |
Enrollment | 15 |
Est. completion date | July 1, 2018 |
Est. primary completion date | June 1, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years and older |
Eligibility |
Inclusion Criteria: Part 1: 1. Age 50 years or older 2. Healthy volunteer without distal radius fracture 3. No restrictions in activities of daily living prior to enrolment* 4. Signed informed consent by participant * Participant should exercises complete self-control over urination and defecation, but use of incontinence material is allowed. Part 2: 1. Patients (50 years or older) with an acute**, unilateral distal radius fracture with dorsal displacement (AO type 23-A, B, or C) that is acceptably reduced (by simple closed reduction with vertical longitudinal traction) 2. No restrictions in activities of daily living pre-fracture* 3. Signed informed consent by patient - Participant should exercises complete self-control over urination and defecation, but use of incontinence material is allowed. ** Patients should report to the Emergency Department within 48h post-trauma. Exclusion Criteria: Part 1: 1. Preexisting anatomical deviation of the ipsi- or contralateral wrist 2. Conditions that affect function of the wrist or hand 3. Insufficient comprehension of the Dutch or language to understand the study documents 4. Participant unwilling or unable to comply with the study protocol and follow-up visit schedule 5. Known allergy for brace material (PLA or alternative) Part 2: 1. Preexisting anatomical deviation of the ipsi- or contralateral wrist 2. Additional traumatic injuries that affect treatment, rehabilitation, or function of the affected hand 3. Pathological, recurrent, or open fracture 4. Impaired wrist function pre-trauma at either wrist (e.g., arthrosis, rheumatoid disorder, or neurological disorder) 5. Bone disorder that may impair bone healing, excluding osteoporosis 6. Patient unwilling or unable to comply with the treatment protocol and follow-up visit schedule 7. Insufficient comprehension of the Dutch language to understand the study documents 8. Known allergy for brace material (PLA or alternative). |
Country | Name | City | State |
---|---|---|---|
Netherlands | VieCuri MC | Venlo | Limburg |
Lead Sponsor | Collaborator |
---|---|
VieCuri Medical Centre | Erasmus Medical Center |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Age (calculated from date of birth and date of enrolment) | - Age (calculated from date of birth and date of enrolment) | At baseline | |
Other | Gender | - Gender (male or female) | At baseline | |
Other | ASA class | - ASA class (1, 2, 3 of 4), assessed in a face-to-face interview | At baseline | |
Other | BMI (calculated from height and weight) | - BMI (calculated from height and weight) | At baseline | |
Other | Tobacco consumption | - Tobacco consumption (current, ever, never) was assessed in a short face-to-face interview | At baseline | |
Other | Alcohol consumption | - Alcohol consumption at enrolment (yes or no), assessed in a face-to-face interview | At baseline | |
Other | Comorbidities including osteoporosis | - Comorbidities including osteoporosis were assessed from the electronic patients dossiers | At baseline | |
Other | Medication use | Medication use was assessed through the electronic patient dossiers | At baseline | |
Other | Dominant side (left or right) | Dominant side was assessed in a face-to-face interview | At baseline | |
Other | Affected side (part 2 only) | - Affected side (left or right) was assessed by the clinician | At baseline | |
Other | Trauma mechanism (low energy/high energy trauma or unknown) | - Trauma mechanism (low energy fall or other, high energy trauma, or unknown) was assessed through face-to-face interview | At baseline | |
Other | Additional injuries (yes or no, with specification) | Additional injuries were assessed in a face-to-face interview Trauma mechanism (low energy fall or other, high energy trauma, or unknown) Additional injuries (yes or no, with specification) Fracture classification (AO type 23-A, B or C) |
At baseline | |
Other | Fracture classification (AO type 23-A, B or C) | - Fracture classification (AO type 23-A, B or C) was diagnosed by the clinician | At baseline | |
Other | Date of scanning | Date of scanning was documented by the clinician | At baseline | |
Other | Date of brace fitting | Date of brace fitting was documented by the clinician. | At baseline | |
Other | Date of brace removal | Date of brace removal was documented by the clinician. If brace was removed early, it was documented how treatment was continued (in patients only). | At baseline | |
Other | Adherence to intervention | Adherence to the intervention was checked (yes/no) and reasons for not adhering were documented by the clinician | At baseline | |
Primary | VAS score | the primary outcome measure will be the change in 1 week (part 1) and over several weeks (part 2) on a 10-centimeter Visual Analog Scale (VAS) score for wearing comfort, in which 0 implies no comfort. and 10 implies extremely comfortable. | Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2 | |
Secondary | Redislocation | Redislocation is determined by the radiologic outcome: Dorsal tilt > 15° on lateral X-ray Volar tilt >20° on lateral X-ray Shortening >5mm pertaining to the ulna in PA direction Intraarticular step-off = 2mm Radial inclination < 15° in PA direction Subluxation of the lunate According to guidelines on these parameters, redislocation is diagnosed. |
Week 1, week 2 and week 5 (only part 2) | |
Secondary | Pain Level | Pain level caused by the brace will be determined using a 10-centimeter Visual Analog Scale (VAS), in which 0 implies no pain and 10 implies the worst possible pain. | Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2 | |
Secondary | Inconvenience | Inconvenience during activities of daily living using the Katz Index. The Katz Index asks for limitations in washing, clothing, indoor transfers, toilet visit, continence and eating. The range for the Katz index is 0 to 6 where 6 indicates full function, 4 indicates moderate impairment and 2 or less indicates severe functional impairment. | Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2 | |
Secondary | Adverse reactions (pain, skin pressure, skin irritation/redness, sensibility issues or device-related problems | Adverse reactions like pain, skin pressure, skin irritation/redness, sensibility issues, or device-related problems. | Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2 |